Search
for
Sort by
Research 511–540 of 640
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Diuretics
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Anagen effluvium
- Scalp melanoma: Distinctive high risk clinical and histological features
- Guidelines for the Use of Acitretin in Psoriasis
- The treatment of alopecia areata
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Diseases of Periocular Hair
- Janus Kinase inhibitors in dermatology: a review
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- National scientific medical meeting 1996 abstracts
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Pemphigus and associated comorbidities: a cross-sectional study
- Association of metabolic syndrome with female pattern hair loss in women: A case-control study
- Drugs that affect autonomic functions or the extrapyramidal system
- Ritlecitinib: First Approval
- Treatment of multiple scalp basal cell carcinomas by photodynamic therapy
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics
- Direct-to-Consumer Teledermatology Growth: A Review and Outlook for the Future
- Acute Alopecia Associated With Albendazole Toxicosis
- Androgenetic Alopecia: What Works?
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Imaging Tools for Noninvasive Hair Assessment